Table of contents

Clinical and epidemiological research

• Extended report: Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) (7 July, 2012)

  Joachim Sieper, Désirée van der Heijde, Maxime Dougados, Philip J Mease, Walter P Maksymowych, Matthew A Brown, Vipin Arora, Aileen L Pangan
• Concise report: Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial (21 November, 2012) Free

  In-Ho Song, Anja Weiß, Kay-Geert A Hermann, Hildrun Haibel, Christian E Althoff, Denis Poddubnyy, Joachim Listing, Ekkehard Lange, Bruce Freundlich, Martin Rudwaleit, Joachim Sieper
• Extended report: Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study (7 June, 2012)

  Frances Rees, Wendy Jenkins, M Doherty
• Extended report: Patients’ needs and expectations with regard to rheumatology nursing care: results of multicentre focus group interviews (10 May, 2013)

  Yvonne van Eijk-Hustings, Judy Ammerlaan, Hanneke Voorneveld-Nieuwenhuis, Bertha Maat, Conny Veldhuizen, Han Repping-Wuts
• Extended report: Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides (7 February, 2013)

  Hege Svean Koksvik, Kåre Birger Hagen, Erik Rødevand, Petter Mowinckel, Tore K Kvien, Heidi A Zangi
• Extended report: Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study (27 June, 2012)

  Jacqueline Detert, Hans Bastian, Joachim Listing, Anja Weiß, Siegfried Wassenberg, Anke Liebhaber, Karin Rockwitz, Rieke Alten, Klaus Krüger, Rolf Rau, Christina Simon, Eva Gremmelsbacher, Tanja Braun, Bettina Marsmann, Vera Höhne-Zimmer, Karl Egerer, Frank Buttgereit, Gerd-R Burmester
• Extended report: Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study) (30 June, 2012)

  Marjatta Leirisalo-Repo, Hannu Kautiainen, Leena Laasonen, Markku Korpela, Markku J Kauppi, Oili Kaipiainen-Seppänen, Riitta Luosujärvi, Reijo Luukkainen, Anna Karjalainen, Harri Blåfield, Toini Uutela, Kirsti Ilva, Heikki A Julkunen, Leena Paimela, Kari Puolakka, Eeva Moilanen, Pekka J Hannonen, Timo Möttönen, for the NEO-RACo Study Group
• Extended report: Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study (13 July, 2012)

  Elisa Gremese, Fausto Salaffi, Silvia Laura Bosello, Alessandro Ciapetti, Francesca Bobbio-Pallavicini, Roberto Caporali, Gianfranco Ferraccioli
• Extended report: Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study (23 June, 2012)

  Mark C Genovese, Patrick Durez, Hanno B Richards, Jerzy Supronik, Eva Dokoupilova, Vadim Mazurov, Jacob A Aelion, Sang-Heon Lee, Christine E Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Shephard Mpofu
• Extended report: ‘Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA’ (30 June, 2012)

  R Koevoets, L Dirven, N B Klarenbeek, M V van Krugten, H K Ronday, D M F M van der Heijde, T W J Huizinga, P S J M Kerstens, W F Lems, C F Allaart
• Extended report: Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity (13 July, 2012)

  Daniel Aletaha, Farideh Alasti, Josef S Smolen
• Extended report: Etanercept normalises left ventricular mass in patients with rheumatoid arthritis (7 August, 2012)

  Claire Immediato Daïen, Pierre Fesler, Guilhem du Cailar, Vincent Daïen, Thibault Mura, Anne-Marie Dupuy, Jean-Paul Cristol, Jean Ribstein, Bernard Combe, Jacques Morel
• Extended report: Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case–control study (24 July, 2012)

  Jaime E Hart, Henrik Källberg, Francine Laden, Tom Bellander, Karen H Costenbader, Marie Holmqvist, Lars Klareskog, Lars Alfredsson, Elizabeth W Karlson
• Extended report: Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry (11 August, 2012)

  Sanne A A van Dartel, Jaap Fransen, Wietske Kievit, Marcel Flendrie, Alfons A den Broeder, H Visser, A Hartkamp, Mart A F J van de Laar, Piet L C M van Riel
• Extended report: Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA) (21 August, 2012)

  Jan M Hughes-Austin, Kevin D Deane, Lezlie A Derber, Jason R Kolfenbach, Gary O Zerbe, Jeremy Sokolove, Lauren J Lahey, Michael H Weisman, Jane H Buckner, Ted R Mikuls, James R O'Dell, Richard M Keating, Peter K Gregersen, William H Robinson, V Michael Holers, Jill M Norris
• Concise report: Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis (17 November, 2012)

  Thierry Dervieux, Michael E Weinblatt, Alan Kivitz, Joel M Kremer
• Extended report: An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW) (23 June, 2012)

  Daniel Prieto-Alhambra, Xavier Nogues, M Kassim Javaid, Allison Wyman, Nigel K Arden, Rafael Azagra, Cyrus Cooper, Jonathan D Adachi, Steven Boonen, Roland D Chapurlat, Juliet E Compston, Stephen H Gehlbach, Susan L Greenspan, Frederick H Hooven, J Coen Netelenbos, Johannes Pfeilschifter, Maurizio Rossini, Philip N Sambrook, Stuart Silverman, Ethel S Siris, Nelson B Watts, Adolfo Díez-Pérez
• Extended report: Cam impingement causes osteoarthritis of the hip: a nationwide prospective cohort study (CHECK) (23 June, 2012)

  Rintje Agricola, Marinus P Heijboer, Sita M A Bierma-Zeinstra, Jan A N Verhaar, Harrie Weinans, Jan H Waarsing
• Extended report: Progression of osteoarthritis as a state of inertia (30 June, 2012)

  David Felson, Jingbo Niu, Burton Sack, Piran Aliabadi, Charles McCullough, Michael C Nevitt
• Extended report: In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis (20 July, 2012)

  Marion C Kortekaas, Wing-Yee Kwok, Monique Reijnierse, Tom W J Huizinga, Margreet Kloppenburg
• Extended report: Evaluation of the genetic overlap between osteoarthritis with body mass index and height using genome-wide association scan data (6 September, 2012)

  Katherine S Elliott, Kay Chapman, Aaron Day-Williams, Kalliope Panoutsopoulou, Lorraine Southam, Cecilia M Lindgren, Nigel Arden, Nadim Aslam, Fraser Birrell, Ian Carluke, Andrew Carr, Panos Deloukas, Michael Doherty, John Loughlin, Andrew McCaskie, William E R Ollier, Ashok Rai, Stuart Ralston, Mike R Reed, Timothy D Spector, Ana M Valdes, Gillian A Wallis, Mark Wilkinson, Eleftheria Zeggini
• Extended report: Co-localisation of non-cartilaginous articular pathology increases risk of cartilage loss in the tibiofemoral joint—the MOST study (6 September, 2012)

  Frank W Roemer, David T Felson, Ke Wang, Michel D Crema, Tuhina Neogi, Yuqing Zhang, Michael C Nevitt, Monica D Marra, Cora E Lewis, James Torner, Ali Guermazi, for MOST study investigators
• Extended report: Incidence and predictors of secondary fibromyalgia in an early arthritis cohort (11 July, 2012)

  Yvonne C Lee, Bing Lu, Gilles Boire, Boulos (Paul) Haraoui, Carol A Hitchon, Janet E Pope, J Carter Thorne, Edward Clark Keystone, Daniel H Solomon, Vivian P Bykerk
• Extended report: Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis (27 June, 2012)

  Eveline Nüesch, Winfried Häuser, Kathrin Bernardy, Jürgen Barth, Peter Jüni
• Concise report: Muscle fatigue in fibromyalgia is in the brain, not in the muscles: a case–control study of perceived versus objective muscle fatigue (8 December, 2012)

  Elisabeth Bandak, Kirstine Amris, Henning Bliddal, Bente Danneskiold-Samsøe, Marius Henriksen
• Extended report: Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI (26 June, 2012)

  Christian E Althoff, Joachim Sieper, In-Ho Song, Hildrun Haibel, Anja Weiß, Torsten Diekhoff, Martin Rudwaleit, Bruce Freundlich, Bernd Hamm, Kay-Geert A Hermann
• Extended report: Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis (10 August, 2012)

  Floris A van Gaalen, Willem Verduijn, Dave L Roelen, Stefan Böhringer, Tom W J Huizinga, Désirée M van der Heijde, René E M Toes
• Extended report: Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort (14 August, 2012)

  Martin Blachier, Bertrand Coutanceau, Maxime Dougados, Alain Saraux, Sylvie Bastuji-Garin, Salah Ferkal, Philippe Le Corvoisier, Valérie Farrenq, Cécile Poulain, Bijan Ghaleh, Florence Canouï-Poitrine, Pascal Claudepierre
• Extended report: The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) (13 July, 2012)

  Philip S Helliwell, Oliver FitzGerald, Jaap Fransen, Dafna D Gladman, Gerald G Kreuger, Kristina Callis-Duffin, Neil McHugh, Philip J Mease, Vibeke Strand, Robin Waxman, Valderilio Feijo Azevedo, Adriana Beltran Ostos, Sueli Carneiro, Alberto Cauli, Luis R Espinoza, John A Flynn, Nada Hassan, Paul Healy, Eduardo Mario Kerzberg, Yun Jong Lee, Ennio Lubrano, Antonio Marchesoni, Helena Marzo-Ortega, Giovanni Porru, Elvia G Moreta, Peter Nash, Helena Raffayova, Roberto Ranza, Siba P Raychaudhuri, Euthalia Roussou, Raphael Scarpa, Yeong Wook Song, Enrique R Soriano, Paul P Tak, Ilona Ujfalussy, Kurt de Vlam, Jessica A Walsh
• Extended report: The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development (3 August, 2012)

  Sibel Z Aydin, Zoe R Ash, Ilaria Tinazzi, Concepción Castillo-Gallego, Chung Kwok, Caroline Wilson, Mark Goodfield, Paolo Gisondi, Ai Lyn Tan, Helena Marzo-Ortega, Paul Emery, Richard J Wakefield, Dennis G McGonagle
• Extended report: Steroid injection for inferior heel pain: a randomised controlled trial (27 June, 2012)

  Elisabeth M A Ball, Helen M A McKeeman, Christopher Patterson, James Burns, Wing Hoi Yau, Owen A Moore, Claire Benson, Joanne Foo, Gary D Wright, Allister J Taggart
• Extended report: Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis (8 September, 2012)

  Alfred Mahr, Sandrine Katsahian, Hugo Varet, Loïc Guillevin, E Christiaan Hagen, Peter Höglund, Peter A Merkel, Christian Pagnoux, Niels Rasmussen, Kerstin Westman, David R W Jayne, for the French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS)
• Extended report: A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients (11 August, 2012)

  Frank Moosig, Jan Phillip Bremer, Bernhard Hellmich, Julia Ulrike Holle, Konstanze Holl-Ulrich, Martin Laudien, Christine Matthis, Claudia Metzler, Bernhard Nölle, Gert Richardt, Wolfgang L Gross
• Extended report: HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus (14 August, 2012)

  Emeli Lundström, Johanna T Gustafsson, Andreas Jönsen, Dag Leonard, Agneta Zickert, Kerstin Elvin, Gunnar Sturfelt, Gunnel Nordmark, Anders A Bengtsson, Ulf Sundin, Henrik Källberg, Johanna K Sandling, Ann-Christine Syvänen, Lars Klareskog, Iva Gunnarsson, Lars Rönnblom, Leonid Padyukov, Elisabet Svenungsson
• Concise report: Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry (21 December, 2012)

  Jacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, Bernard Combe, Eric Hachulla, Olivier Meyer, Edouard Pertuiset, Guy Kaplanski, Laurent Chiche, Jean-Marie Berthelot, Bruno Gombert, Philippe Goupille, Christian Marcelli, Séverine Feuillet, Jean Leone, Jean Sibilia, Charles Zarnitsky, Philippe Carli, Stephanie Rist, Philippe Gaudin, Carine Salliot, Muriel Piperno, Adeline Deplas, Maxime Breban, Thierry Lequerre, Pascal Richette, Charles Ghiringhelli, Mohamed Hamidou, Philippe Ravaud, Xavier Mariette